#186 - Etology, Clinical Profile and Long-term Survival After Liver Transplantation for Acute Liver Failure
Year: 2026
Type: article
Study design: Observational Study
Abstract: Introduction and Objectives Acute liver failure (ALF) requiring liver transplantation is a high-acuity condition with heterogeneous etiologies and limited long-term data in Latin America. We aimed to describe the clinical profile, etiologies, pre-transplant severity, and post-transplant survival of patients transplanted for ALF at a tertiary center in Chile. Materials and Methods We conducted a retrospective single-center cohort study including all patients who underwent liver transplantation for ALF. Demographic, etiologic, clinical, and transplant-related variables were collected. Post-transplant survival was estimated using Kaplan-Meier analysis, with follow-up through April 2025. Results Sixty-seven patients were included. Mean age was 38.7 ± 15.0 years, 77.6% were female, and 91.0% met King’s College criteria. Mean MELD-Na was 31.6 ± 8.6, and mean waiting-list time was 5.7 ± 6.4 days. Deceased donor transplantation was performed in 95.5%. Pre-transplant severity was high: grade IV hepatic encephalopathy occurred in 58.2%, mechanical ventilation in 67.2%, vasoactive drug requirement in 56.7%, cerebral edema in 34.3%, seizures in 22.4%, renal replacement therapy in 13.4%, and pre-transplant infection in 14.9%. Leading etiologies were autoimmune hepatitis (40.3%) and cryptogenic ALF (38.8%), followed by hepatitis A virus (6.0%), and acetaminophen, hepatitis B virus, and other drugs (4.5% each). Estimated survival was 74.6% at 1 month, 66.9% at 1 year, 63.6% at 5 years, and 56.6% at 15 years. Conclusions In this cohort, ALF requiring liver transplantation predominantly affected young women and was mainly attributable to autoimmune hepatitis or cryptogenic causes, suggesting a distinct etiologic pattern compared with other reported international series. Despite marked pre-transplant severity, long-term post-transplant survival was sustained.
Source: Annals of Hepatology
Institution: Pontificia Universidad Católica de Chile
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,500
OpenAlex ID: W7204229704
